University of Birmingham study finds digoxin may aid in managing heart failure
A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost…
A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost…
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for…
With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market…
In December 2024, the American Academy of Pediatrics published an updated screening algorithm for critical congenital heart defects (CCHD). According…
Following positive data reported earlier this year from a Phase I/II trial, Sequana Medical has touted results from a study…
According to a 2023 survey by the American Psychiatric Association, work-related stress affects approximately 77% of the US working population.…
On November 18, at the American Heart Association (AHA) 100th Annual Meeting 2024, the safety of glucagon-like peptide-1 receptor (GLP-1R)…
Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a…
Penumbra has posted positive data for its computer-assisted vacuum thrombectomy (CAVT) technology aimed at treating patients with intermediate-risk pulmonary embolism…
Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral…